PharmaTher develops 3D printed colon-targeted peptide tablets
Toronto-based PharmaTher Holdings is developing oral KPV and BPC-157 peptide tablets, 3D printed on its M3DICINES platform to release their dose in the colon, for sale through a…
MH
By Maren Holt · Senior Reporter, GLP-1
Nov 1 11:47 ETSource: VoxelMatters
From the source
Read at voxelmatters.comPharmaTher develops 3D printed colon-targeted peptide tablets
Toronto-based PharmaTher Holdings is developing oral KPV and BPC-157 peptide tablets, 3D printed on its M3DICINES platform to release their dose in the colon, for sale through a new U.S. compounding pathway.
